Pacira BioSciences, Inc. (PCRX : NASDAQ)
Common Stock
$36.39
USD
+11.19 (44.40%)
Last updated: 2026-10-08
Follow PCRX
PCRX
Pacira BioSciences, Inc.
WealthAwesomePerformance
1 Day
+44.40%
1 Week
+45.50%
1 Month
+40.66%
YTD
+60.73%
Key Statistics
Market Cap
$1.45B
52W High
$36.46
52W Low
$18.80
P/E Ratio
103.97
50 Day MA
$25.38
200 Day MA
$23.93
Beta
0.25
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/8/2026 | $36.33 | $36.46 | $36.27 | $36.39 | $36.39 | 28,867,642 |
| 10/7/2026 | $25.05 | $26.00 | $24.99 | $25.20 | $25.20 | 802,729 |
| 10/6/2026 | $25.13 | $25.25 | $24.56 | $24.76 | $24.76 | 493,100 |
| 10/5/2026 | $25.37 | $25.71 | $24.83 | $25.05 | $25.05 | 560,209 |
| 10/2/2026 | $25.04 | $25.66 | $24.66 | $25.21 | $25.21 | 469,800 |
| 10/1/2026 | $25.05 | $25.38 | $24.93 | $25.01 | $25.01 | 510,598 |
| 9/30/2026 | $25.59 | $25.77 | $24.91 | $25.05 | $25.05 | 596,142 |
| 9/29/2026 | $25.30 | $25.67 | $25.13 | $25.65 | $25.65 | 521,037 |
| 9/28/2026 | $25.15 | $25.76 | $24.79 | $25.39 | $25.39 | 478,754 |
| 9/25/2026 | $25.50 | $25.66 | $25.00 | $25.12 | $25.12 | 444,200 |
Analyst Price Targets
Based on 9 analysts covering PCRX · as of Oct 9, 2026
Wall Street analysts forecast PCRX stock price to fall 13.7% over the next 12 months.
Consensus
Buy3.89 / 5.00
Avg. Target
US$31.39
-13.7% Upside
Previously US$30.11 on Oct 8, 2026
Current Price
US$36.39
Last close
Analyst Breakdown (9 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PCRX's historical volatility
30-Day Vol
110.3%
Annualized
90-Day Vol
74.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$43.50
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$38.62 | US$26.40 – US$56.51 |
| 60 trading days | US$40.99 | US$23.93 – US$70.22 |
| 90 trading days | US$43.50 | US$22.50 – US$84.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Pacira BioSciences, Inc.
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.
Financials
- Revenue (TTM)
- $746.16M
- EBITDA
- $123.97M
- Profit Margin
- 1.96%
- ROE (TTM)
- 2.05%
- EPS (Diluted)
- 0.35
- Book Value
- 16.87
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About PCRX.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| FLYE | Fly-E Group, Inc. Common Stock | $2.32 | +82.68% |
| JZ | Jianzhi Education Technology Group Company Limited American Depositary Shares | $0.83 | +77.52% |
| EURKR | Eureka Acquisition Corp Right | $0.44 | +62.87% |
| AIXI | XIAO-I Corporation | $1.93 | +46.21% |
| QNME | Quanome Technologies, Inc. | $0.83 | +43.28% |
| OLB | OLB Group Inc | $0.55 | +41.86% |
| RITRF | Reitar Logtech Holdings Limited | $0.01 | +33.33% |
| RFAIR | RF Acquisition Corp II Right | $0.19 | +28.38% |